Guillain-Barre syndrome (GBS) is a rare complication following hematopoietic stem cell transplantation (HSCT), and its pathogenesis remains unclear. GBS in the early post transplant period has been attributed to the conditioning regimen, particularly cytosine arabinoside. 1 In contrast, the etiology of GBS in the late post transplant period remains unknown. 2 Some reports suggest an association with antecedent infections such as cytomegalovirus (CMV) and Campylobacter pylori. As few cases of GBS during acute graft-versus-host disease (acute GVHD) have been reported, acute GVHD is unlikely to be the cause of GBS. 2 We report a patient who developed GBS during rapid immune reconstitution following allogeneic HSCT.
A 34-year-old woman with acute lymphoblastic leukemia in the second remission underwent allogeneic peripheral blood stem cell transplantation from a one-antigenmismatched related donor. The conditioning regimen comprised of cyclophosphamide and busulfan. GVHD prophylaxis was cyclosporine and short-term methotrexate. Diffuse erythema and diarrhea appeared on day 20; acute GVHD was diagnosed after skin biopsy. We initiated methylprednisolone 1 mg/kg, to which GVHD gradually responded. On day 30, she developed abdominal pain and was positive for CMV pp65 antigenemia. CMV colitis was diagnosed after colonoscopy with tissue biopsy. Her symptoms gradually improved with ganciclovir, and CMV antigenemia turned negative on day 70. On day 78, she complained of muscle weakness in the lower extremities, which progressed to quadriplegia on day 85. Muscle weakness was prominent in the proximal lower extremities. Deep tendon reflexes were absent in all the four extremities. Autonomic nervous and sensory function remained clinically normal. Magnetic resonance images of the whole spinal cord failed to show any abnormalities. Cerebrospinal fluid (CSF) showed normal levels of cell counts, protein, and glucose. CSF cultures and polymerase chain reaction using CMV-specific primers were negative. Serological tests for myasthenia gravis and anti-ganglioside antibody were also negative. Nerve conduction studies showed no conduction blocks, while the amplitudes of action potentials of compound muscle and sensory nerve were abnormally reduced. Electromyelography showed fibrillation potentials and positive sharp waves, which were consistent with denervation of muscle fibers. A sural nerve biopsy revealed axonal degeneration with infiltration of CD8 þ T cells and macrophages. Based on these findings, axonal type GBS was diagnosed. Notably, the serum IgG level rapidly increased, when the patient developed GBS (Figure 1 ). Electrophoresis of serum immunoglobulin revealed no clonality. Single strand conformation polymorphism (SSCP) analysis of T-cell receptor (TCR) Vb genes amplified by the reverse transcription-polymerase chain reaction from peripheral blood mononuclear cells on day 78 showed several distinct bands of TCR Vb genes ( Figure 2 ). This indicates clonal expansions of T cells. SSCP analysis of peripheral blood mononuclear cells showed that some TCR clonotypes of post transplant patient T cells were identical to those of donor T cells. These findings demonstrate that donorderived mature T cells expanded clonally in the peripheral pool when the patient developed GBS.
We initiated high-dose immunoglobulin therapy on day 88, but to no avail. Immune suppression was not intensified, and the serum concentration of cyclosporine was maintained at around 80 ng/dl. Plasma exchange was not conducted in this patient, since there is little evidence supporting its usefulness for GBS following HSCT. Her muscle strength remained unchanged from day 85 to day 148. On day 150, the patient displayed rapid recovery of muscle strength. On day 230, she could walk with assistance. She developed no symptoms of chronic GVHD. She was discharged on day 250.
The clinical course of the present patient provides important information about the pathogenesis of GBS following HSCT. She had not presented with the typical features of GBS such as an increase in CSF protein and anti-ganglioside antibodies. These findings suggest differences in the pathogenesis between GBS in the nontransplant setting and that following HSCT. A sural nerve biopsy showed infiltration of T cells and macrophages, suggesting an immune-mediated pathogenesis. GVHD was suspected to be an etiological factor in the immunemediated pathogenesis. However, symptoms of acute GVHD had already resolved at the onset of GBS, and GBS improved without intensifying immune suppression. These findings are consistent with previous reports. 2 It is reasonable to assume that GBS following HSCT would be attributable to immune-mediated mechanisms other than GVHD.
Her clinical course suggests an association between the antecedent CMV infection and GBS. In the previous reports, two types of peripheral neuropathy owing to CMV infection have been noted: direct damage of infected neural cells and immune-mediated 'cross-reacting mechanism'. 3, 4 In this patient, direct neural involvement by CMV was unlikely, because GBS developed after CMV antigenemia disappeared and neural symptoms resolved without anti-CMV therapy. A humorally mediated 'crossreacting mechanism' was attributable to CMV-related GBS in a non-transplant patient. 4 This could be a possible etiology of GBS following HSCT; however, the clinical symptoms of this patient were distinct from those of CMV-related GBS in the non-transplant setting. Nontransplant patients with CMV-related GBS frequently develop sensory loss (90%), cranial nerve involvement (80%), and respiratory insufficiency (65%). 5, 6 These clinical differences suggest that a humorally mediated crossreacting mechanism was not likely in this patient.
Most notably, the development of GBS is associated with rapid immune recovery, which has been suggested as a possible cause of immune dysregulation. 7, 8 In the early post transplant period, naive B cells in the marrow and mature T cells in the peripheral blood expand oligoclonally in response to antigenic stimulation such as CMV. 9 Both expanded populations of lymphocytes could contribute to the immune dysregulation. 7, 8, 10 Oligoclonally expanded naive B cells produce autoantibodies. 10 Peripheral expansions of mature T cells generate self-reacting T cells, possibly because proliferation is not regulated by the thymus. 7, 8, 10 In this patient, immunological analysis revealed clonalities of donor-derived mature T cells. A sural nerve biopsy showed infiltration of T cells and few deposits of immunoglobulins. In addition serum anti-ganglioside antibodies, the presence of which in non-transplant GBS patients is the basis for the hypothesis of humorally mediated cross reacting mechanism, were absent. Taken together with these findings, it is reasonable to assume that GBS following HSCT might be attributable to peripheral expansion of mature lymphocytes following CMV infection.
In conclusion, we describe an HSCT patient who developed proximal-dominant, axonal motor-sensory type of GBS. The patient's symptoms resolved with supportive therapy. The clinical course suggests that peripheral expansion of mature T cells following CMV infection may be an etiological factor in GBS following HSCT. 
